> top > docs > PMC:7558914 > spans > 19603-20752 > annotations

PMC:7558914 / 19603-20752 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
482 899-911 Gene denotes interferon-β Gene:3456
483 300-308 Species denotes patients Tax:9606
484 443-451 Species denotes patients Tax:9606
485 1121-1129 Species denotes patients Tax:9606
486 0-19 Chemical denotes Lopinavir/ritonavir MESH:C558899
487 59-77 Chemical denotes hydroxychloroquine MESH:D006886
488 78-89 Chemical denotes chloroquine MESH:D002738
489 407-417 Chemical denotes Remdesivir MESH:C000606551
490 535-545 Chemical denotes remdesivir MESH:C000606551
491 792-803 Chemical denotes oseltamivir MESH:D053139
492 805-815 Chemical denotes umifenovir MESH:C086979
493 817-828 Chemical denotes favipiravir MESH:C462182
494 833-842 Chemical denotes ribavirin MESH:D012254
495 883-898 Chemical denotes interferon-α or
496 314-322 Disease denotes COVID-19 MESH:C000657245
497 643-652 Disease denotes mortality MESH:D003643
498 965-973 Disease denotes COVID-19 MESH:C000657245
499 1135-1143 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T127 0-142 Sentence denotes Lopinavir/ritonavir has had the same limitations of use as hydroxychloroquine/chloroquine, with no clear benefits beyond standard care [3,23].
T128 143-406 Sentence denotes Considering the uncertainty and the likely increase in gastrointestinal side effects, principal guidelines around the world have not contemplated its use in patients with COVID-19 [4,18,19,20] or have only considered it in the context of a clinical trial [21,22].
T129 407-486 Sentence denotes Remdesivir was only considered when patients were enrolled in a clinical trial.
T130 487-703 Sentence denotes Randomized controlled trials have reported that remdesivir reduces the duration of mechanical ventilation and time to symptom resolution, but its effect on mortality and other adverse outcomes remains uncertain [24].
T131 704-766 Sentence denotes Other antivirals were not routinely included in our protocols.
T132 767-978 Sentence denotes Antiviral agents such as oseltamivir, umifenovir, favipiravir, or ribavirin as well as miscellaneous agents such as interferon-α or interferon-β are being studied for use as possible treatments for COVID-19 [3].
T133 979-1149 Sentence denotes Currently, principal guidelines have either not reported any recommendation for their use [4,18,19,20,21] or have suggested not using them in patients with COVID-19 [22].